The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.120.6.597

Imipramine in 25 mg. daily doses was found to be an effective agent for the control of enuresis. In a double-blind study, 17 of 23 (74%) severely enuretic boys showed marked improvement on the drug compared to the placebo when each medication was given for 20 days. Nightly incidence of enuresis was reduced from a mean of 70% to 47%. This difference is highly significant (P<0.001). Further trials over longer periods should be helpful in evaluating the possibility of complete enuretic control following discontinuation of the drug.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.